,
, Cancer Radiother J Soc Francaise Radiother Oncol, vol.19, pp.3-9, 2015.
Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases, J Clin Oncol ,
Radiosurgery for brain metastases: a score index for predicting prognosis, Int J Radiat Oncol Biol Phys, vol.46, pp.1155-61, 2000. ,
Multivariate analysis of factors predictive of brain metastases in localised non-small cell lung carcinoma, Lung Cancer Amst Neth, vol.45, pp.317-340, 2004. ,
Brain metastases in locally advanced nonsmall cell lung carcinoma after multimodality treatment: risk factors analysis, Cancer, vol.95, pp.605-617, 2002. ,
Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma, Cancer, vol.94, pp.2698-705, 2002. ,
Estimating Survival in Patients With Lung Cancer and Brain Metastases: An Update of the Graded Prognostic Assessment for Lung Cancer Using Molecular Markers (Lung-molGPA) ,
, JAMA Oncol, vol.3, pp.827-858, 2017.
Brain metastases at the time of presentation of non-small cell lung cancer: a multi-centric AERIO analysis of prognostic factors, Br J Cancer, vol.84, pp.903-912, 2001. ,
Incidence and prognosis of patients with brain metastases at diagnosis of systemic malignancy: a population-based study, Neuro-Oncol, vol.19, pp.1511-1532, 2017. ,
The impact of brain metastasis on quality of life, resource utilization and survival in patients with non-small-cell lung cancer, Cancer Treat Rev, vol.45, pp.139-62, 2016. ,
, Collège National des Gynécologues et Obstétricien Francais -Université médicale virtuelle francophone
Central nervous system metastasis from breast carcinoma. Autopsy study, Cancer, vol.52, pp.2349-54, 1983. ,
Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System, J Clin Oncol, vol.22, pp.2865-72, 2004. ,
Metastatic behavior of breast cancer subtypes, J Clin Oncol, vol.28, pp.3271-3278, 2010. ,
Sites of distant recurrence and clinical outcomes in patients with metastatic triple-negative breast cancer: high incidence of central nervous system metastases, Cancer, vol.113, pp.2638-2683, 2008. ,
Brain metastases from breast cancer: identification of a high-risk group, Clin Oncol R Coll Radiol G B, vol.16, pp.345-354, 2004. ,
Central nervous system metastases in HER-2 positive metastatic breast cancer patients treated with trastuzumab: incidence, survival, and risk factors, The Oncologist, vol.12, pp.766-73, 2007. ,
Risk factors for brain relapse in patients with metastatic breast cancer, Ann Oncol, vol.15, pp.1640-1644, 2004. ,
Predictors of central nervous system metastasis in patients with metastatic breast cancer. A competing risk analysis of 579 patients treated with epirubicin-based chemotherapy, Breast Cancer Res Treat, vol.91, pp.217-242, 2005. ,
The effect of tumor subtype on the time from primary diagnosis to development of brain metastases and survival in patients with breast cancer, J Neurooncol, vol.112, pp.467-72, 2013. ,
Clinicopathologic characteristics and prognostic factors in 420 metastatic breast cancer patients with central nervous system metastasis, Cancer, vol.110, pp.2640-2647, 2007. ,
Identification of an optimal subgroup for treatment evaluation of patients with brain metastases using RTOG study 7916, Int J Radiat Oncol Biol Phys, vol.16, pp.669-73, 1989. ,
Clinicopathological characteristics at primary melanoma diagnosis as risk factors for brain metastasis, Melanoma Res, vol.23, pp.461-468, 2013. ,
Clinicopathological characteristics at primary melanoma diagnosis as risk factors for brain metastasis, Melanoma Res, vol.23, pp.461-468, 2013. ,
Prognostic factors for survival in melanoma patients with brain metastases, Cancer, vol.117, pp.1687-96, 2011. ,
Predictive factors for the development of brain metastasis in advanced unresectable metastatic melanoma, Am J Clin Oncol, vol.34, pp.603-613, 2011. ,
Predictive factors for the development of brain metastases in patients with malignant melanoma: a study by the Anatolian society of medical oncology, J Cancer Res Clin Oncol, vol.140, pp.151-158, 2014. ,
Metastatic melanoma: prognostic factors and survival in patients with brain metastases, J Neurooncol, vol.135, pp.507-519, 2017. ,
NRAS mutation status is an independent prognostic factor in metastatic melanoma, Cancer, vol.118, pp.4014-4037, 2012. ,
Clinical variables and primary tumor characteristics predictive of the development of melanoma brain metastases and post-brain metastases survival, Cancer, vol.117, pp.1711-1731, 2011. ,
Treatment of melanoma brain metastases: a new paradigm, Cancer J Sudbury Mass, vol.18, pp.208-220, 2012. ,
Brain and leptomeningeal metastases from cutaneous melanoma: survival outcomes based on clinical features, Neuro-Oncol, vol.10, pp.199-207, 2008. ,
Colorectal cancer metastatic to the brain: time trends in presentation and outcome, Oncology, vol.76, pp.369-74, 2009. ,
Brain metastasis from renal cell carcinoma: presentation, recurrence, and survival, Cancer, vol.113, pp.1641-1649, 2008. ,
Prognostic Factors for Survival of Patients With Synchronous or Metachronous Brain Metastasis of Renal Cell Carcinoma, Clin Genitourin Cancer, vol.15, pp.717-740, 2017. ,
Improved Survival Outcomes for Kidney Cancer Patients With Brain Metastases, Clin Genitourin Cancer, vol.17, pp.263-72, 2019. ,
Brain metastases from colorectal cancer: risk factors, incidence, and the possible role of chemokines, Clin Colorectal Cancer, vol.8, pp.100-105, 2009. ,
Characteristics and prognosis of patients with colorectal cancer-associated brain metastases in the era of modern systemic chemotherapy, J Neurooncol, vol.104, pp.745-53, 2011. ,
Clinical characteristics and treatment outcomes of patients with colorectal cancer who develop brain metastasis: a single institution experience, J Gastrointest Oncol, vol.8, pp.55-63, 2017. ,
RAS mutations affect pattern of metastatic spread and increase propensity for brain metastasis in colorectal cancer, Cancer, vol.121, pp.1195-203, 2015. ,
, ANOCEF -Association des Neuro-oncologues d'Expression Française
, Nanterre : Santor Edition
,
, Cancer Radiother, vol.20, pp.80-87, 2016.
A randomized trial of surgery in the treatment of single metastases to the brain, N Engl J Med, vol.322, pp.494-500, 1990. ,
Factors influencing the risk of local recurrence after resection of a single brain metastasis, J Neurosurg, vol.113, pp.181-190, 2010. ,
Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus wholebrain irradiation: a randomised controlled trial, Lancet Oncol, vol.10, pp.1037-1081, 2009. ,
Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial, Lancet Oncol, vol.18, pp.1049-60, 2017. ,
The stereotaxic method and radiosurgery of the brain, Acta Chir Scand, vol.102, pp.316-325, 1951. ,
Fractionated stereotactic radiotherapy using CyberKnife for the treatment of large brain metastases: a dose escalation study, Clin Oncol R Coll Radiol G B, vol.26, pp.151-159, 2014. ,
Volume specific response criteria for brain metastases following salvage stereotactic radiosurgery and associated predictors of response, Acta Oncol Stockh Swed, vol.51, pp.629-664, 2012. ,
Incidence of radionecrosis in single-fraction radiosurgery compared with fractionated radiotherapy in the treatment of brain metastasis, Curr Oncol Tor Ont, vol.26, pp.328-361, 2019. ,
Radiosurgery for Large Brain Metastases, Int J Radiat Oncol, vol.83, pp.113-133, 2012. ,
Single-Fraction Versus Multifraction (3 × 9 Gy) Stereotactic Radiosurgery for Large (>2 cm) Brain Metastases: A Comparative Analysis of Local Control and Risk of Radiation-Induced Brain Necrosis, Int J Radiat Oncol Biol Phys, vol.95, pp.1142-1150, 2016. ,
Prescription to 50-75% isodose line may be optimum for linear accelerator based radiosurgery of cranial lesions, J Radiosurgery SBRT, vol.3, pp.139-186, 2014. ,
Dose gradient analyses in Linac-based intracranial stereotactic radiosurgery using Paddick's gradient index: consideration of the optimal method for plan evaluation, J Radiat Res (Tokyo), vol.52, pp.592-601, 2011. ,
Efficacy and Safety of Fractionated Stereotactic Radiosurgery for Large Brain Metastases, J Korean Neurosurg Soc, vol.58, pp.217-241, 2015. ,
Outcome evaluation of patients treated with fractionated Gamma Knife radiosurgery for large (> 3 cm) brain metastases: a dose-escalation study, J Neurosurg, vol.2019, pp.1-10 ,
T1/T2 matching to differentiate tumor growth from radiation effects after stereotactic radiosurgery, Neurosurgery, vol.66, pp.491-492, 2010. ,
Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05, Int J Radiat Oncol Biol Phys, vol.47, pp.291-299, 2000. ,
Stereotactic radiosurgery for brain metastases: analysis of outcome and risk of brain radionecrosis, Radiat Oncol Lond Engl, vol.6, p.48, 2011. ,
Fractionated stereotactic radiosurgery for patients with brain metastases, J Neurooncol, vol.117, pp.295-301, 2014. ,
Irradiated volume as a predictor of brain radionecrosis after linear accelerator stereotactic radiosurgery, Int J Radiat Oncol Biol Phys, vol.77, pp.996-1001, 2010. ,
Single versus Multifraction Stereotactic Radiosurgery for Large Brain Metastases: An International Meta-analysis of 24 Trials, Int J Radiat Oncol Biol Phys, vol.103, pp.618-648, 2019. ,
Stereotactic radiotherapy for large solitary brain metastases, Cancer Radiother J Soc Francaise Radiother Oncol, vol.18, pp.97-106, 2014. ,
Treatment of Large Brain Metastases With Stereotactic Radiosurgery, Technol Cancer Res Treat, vol.15, pp.186-95, 2016. ,
Fractionated Stereotactic Gamma Knife Radiosurgery for Large Brain Metastases: A Retrospective, Single Center Study. PloS One, vol.11, p.163304, 2016. ,
Five-fraction CyberKnife radiotherapy for large brain metastases in critical areas: impact on the surrounding brain volumes circumscribed with a single dose equivalent of 14 Gy (V14) to avoid radiation necrosis, J Radiat Res (Tokyo), vol.55, pp.334-376, 2014. ,
Three-fraction CyberKnife radiotherapy for brain metastases in critical areas: referring to the risk evaluating radiation necrosis and the surrounding brain volumes circumscribed with a single dose equivalence of 14 Gy (V14), J Radiat Res (Tokyo), vol.54, pp.727-762, 2013. ,
Three-staged stereotactic radiotherapy without whole brain irradiation for large metastatic brain tumors, Int J Radiat Oncol Biol Phys, vol.74, pp.1543-1551, 2009. ,
Long-term risk of radionecrosis and imaging changes after stereotactic radiosurgery for brain metastases, J Neurooncol, vol.125, pp.149-56, 2015. ,
Volumetric changes of intracranial metastases during the course of fractionated stereotactic radiosurgery and significance of adaptive planning, J Neurosurg, vol.2019, pp.1-6 ,
Fractionated stereotactic radiosurgery for large brain metastases, Am J Clin Oncol, vol.38, pp.135-144, 2015. ,
Comparative effectiveness of multi-fraction stereotactic radiosurgery for surgically resected or intact large brain metastases from non-small-cell lung cancer (NSCLC), Lung Cancer Amst Neth, vol.132, pp.119-144, 2019. ,
Predicting the response of head and neck cancers to radiation therapy with a multivariate modelling system: an analysis of the RTOG head and neck registry, Int J Radiat Oncol Biol Phys, vol.10, pp.481-488, 1984. ,
Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials, Int J Radiat Oncol Biol Phys, vol.37, pp.745-51, 1997. ,
Comparison of Local Control of Brain Metastases With Stereotactic Radiosurgery vs Surgical Resection: A Secondary Analysis of a Randomized Clinical Trial, JAMA Oncol, vol.5, pp.243-250, 2019. ,
Image-guided craniotomy for cerebral metastases: techniques and outcomes, Neurosurgery, vol.61, pp.349-56, 2007. ,
Functional approach using intraoperative brain mapping and neurophysiological monitoring for the surgical treatment of brain metastases in the central region, J Neurosurg, vol.126, pp.698-707, 2017. ,
Accuracy of F-DOPA PET and perfusion-MRI for differentiating radionecrotic from progressive brain metastases after radiosurgery, Eur J Nucl Med Mol Imaging, vol.42, pp.103-114, 2015. ,